AMIA joined with over 200 organizations, submitted a joint letter urging the DEA to finalize regulations for a special registration process that would permit telemedicine prescribing of controlled substances without requiring in-person visits. The letter emphasizes that delays in finalizing these rules jeopardize access to care for patients relying on […]
AMIA commented supporting NIH's three-stage AI strategy progression from data analytics to autonomous biomedical AI systems. We emphasized AI principles including explainability, fairness, transparency, and accountability. Key recommendations include requiring FAIR data principles for federal grants, mandating explainable AI methods, establishing "algorithmovigilance" for continuous monitoring, and developing comprehensive AI competency […]
AMIA responded to the NIH National Library of Medicine's Request for Information on future biomedical informatics research priorities. The organization addressed three key areas:
(A) Vision for the Future, highlighting unmet needs in multi-modal data integration, temporal health modeling, and precision prevention; key challenges in causal inference, real-time adaptive learning […]
